The coronavirus proofreading exoribonuclease mediates extensive viral recombination

Jennifer Gribble(Vanderbilt University), Mark R. Denison(Bipar), Laura J. Stevens(Vanderbilt University Medical Center), Xiaotao Lu(Vanderbilt University Medical Center), Andrew Routh(Scripps Research Institute), James D. Chappell(King Saud bin Abdulaziz University for Health Sciences), Andrea J. Pruijssers(Vanderbilt Health), Maria L. Agostini(VIR Biotechnology (United States)), Jordan Anderson-Daniels(Vanderbilt University Medical Center)
bioRxiv (Cold Spring Harbor Laboratory)
April 25, 2020
10.1101/2020.04.23.057786
Cited by 33

Related Papers

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
|New England Journal of Medicine|2015|3.4k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children
|New England Journal of Medicine|2015|1.9k
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
|Nature|2020|1.7k
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
|mBio|2018|1.5k
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k